The Effect of Fetuin-A and Other Laboratory Paremeters on Prognosis and Mortality in Crimean-Congo Hemorrhagic Fever
,
Abstract
Background: Crimean-Congo Hemorrhagic Fever (CCHF) is a disease with high morbidity and mortality, which is an important health problem in the world. Therefore, we aimed to evaluate the effects of plasma fetuin-A (FA) level, which is a new parameter in terms of prognosis and mortality of CCHF.
Methods: A total of 87 patients were included who presented to the Emergency Department, Bağcılar Training and Research Hospital, İstanbul, Turkey with the diagnosis of CCHF from Feb 1, 2019 to Feb 1, 2020. The patients were divided into three groups as tick bite, contact history, and endemic area travel according to the transmission type, and two groups according to the presence of mortality or not. The laboratory data of the patients were compared within these groups. Relationship of hemogram, C-reactive protein (CRP), D-Dimer, sedimentation, lactate, and FA levels between groups were evaluated.
Results: The average age of the patients was 62.52±14.94 years and 27(31%) of them were women. Mortality rates were in 6(6.9%) patients from endemic areas (P=0.015). While the FA level of the mortality group was 171.6±30.0 mg/L, it was 230.3±25.0 mg/L in the survivors (P=0.001). There was a moderate and strong negative correlation of FA level with mortality, tick history, and hospitalization. In ROC curve analysis of mortality and FA levels, parameters were determined as sensitivity 97.4% and specificity 96.2%.
Conclusion: In addition to FA levels, as anticipated by our hypothesis, lactate, CRP, and sedimentation values can be used to predict prognosis and mortality in cases of CCHF.
2. Shayan S, Bokaean M, Shahrivar MR, Chini-kar S (2015). Crimean-Congo hemor-rhagic fever. Lab Med, 46: 180-9.
3. Bente DA, Forrester NL, Watts DM, et al (2013). Crimean-Congo hemorrhagic fe-ver: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res, 100: 159-89.
4. Crimean-Congo haemorrhagic fever. Gene-va: Switzerland: World Health Organiza-tion 2016. Available from: http://www.who.int/csr/disease/crimean_congoHF /en/ (Accessed on March 6, 2016).
5. Elaldı N (2004). Epidemiology of Crimean-Congo Hemorrhagic Fever. Cumhuriyet Medical Journal, 26(4): 185-90.
6. Tarantola A, Nabeth P, Tattevin P, et al (2006). Incident Management Group. Lookback exercise with imported Crime-an-Congo hemorrhagic fever, Senegal and France. Emerg Infect Dis, 12: 1424-6.
7. Johnson S, Henschke N, Maayan N, et al (2018). Ribavirin for treating Crimean Congo haemorrhagic fever. Cochrane Da-tabase Syst Rev, 6: CD012713.
8. Leblebicioglu H, Bodur H, Dokuzoguz B, et al (2012). Case management and support-ive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis, 12: 805-11.
9. Pederson KO (1944). Fetuin, a New Globu-lin Isolated from Serum. Nature, 154:575.
10. Olivier E, Soury E, Ruminy P, et al (2000). Fetuin-B, a second member of the fetuin family in mammals. Biochem J, 350: 589-97.
11. Wang H, Sama AE (2012). Anti-inflammatory role of fetuin-A ininjury and infection. Curr Mol Med, 12: 625-33.
12. Dziegielewska KM, Daikuhara Y, Ohnishi T, et al (2000). Fetuin in the developing neo-cortex of the rat: distribution and origin. J Comp Neurol, 423(3): 373-88.
13. Gok SE (2016). Crimean-Congo Hemor-rhagic Fever. Okmeydanı Medical Journal, 32: 13-9.
14. Akıncı E, Bodur H, Leblebicioglu H (2013). Pathogenesis of Crimean- Congo hem-orrhagic fever. Vector Borne Zoonotic Dis, 13: 429-37.
15. Peters CJ, Zaki SR (2002). Role of the endo-thelium in viral hemorrhagic fevers. Crit Care Med, 30(5): 268-73.
16. Bray M (2007). Comparative pathogenesis of Crimean Congo hemorrhagic fever and Ebola hemorrhagic fever. In: Ergon-ul O, Whitehouse CA. Dordrecht, NL, eds. Crimean Congo Hemorrhagic Fever: A Global Perspective. Springer, p.221-231.
17. Ergonul O, Tuncbilek S, Baykam N et al (2006). Evaluation of serum levels of in-terleukin (IL)-6, IL-10, and tumor necro-sis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis, 193(7): 941-4.
18. Erenler AK, Kulaksiz F, Ülger H, et al (2015). Predictors of Crimean-Congo hemorrhagic fever in the Emergency De-partment. Eur Rev Med Pharmacol Sci, 19(20): 3811-6.
19. Bastug A, Kayaaslan B, Kazancioglu S, et al (2016). Crimean-Congo Hemorrhagic Fever: Prognostic Factors and the Asso-ciation of Leukocyte Counts with Mor-tality. Jpn J InfectDis, 69(1): 51-5.
20. Koksal I, Yilmaz G, Aksoy F, et al (2010). The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol, 47(1): 65-8.
21. Onguru P, Akgul EO, Akinci E, et al (2008). High serum levels of neopterin in pa-tients with Crimean-Congo hemorrhagic fever and its relation with mortality. J In-fect, 56(5): 366-70.
22. Jones AE, Shapiro NI, Trzeciak S, et al (2010). Lactate clearancevs central venous oxygen saturation as goals of early sepsist herapy: a randomized clinical trial. JAMA, 303(8): 739-46.
23. Arnold RC, Shapiro NI, Jones AE, et al (2009). Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock, 32(1): 35-9.
24. Fisher E, Stefan N, Saar K, et al (2009). As-sociation of AHSG gene polymorphisms with fetuin-A plasma levels and cardio-vascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet, 2(6): 607-13.
25. Westenfeld R, Jahnen-Dechent W, Ketteler M (2007). Vascular calcification and fetu-in-A deficiency in chronic kidney disease. Trends Cardiovasc Med, 17(4): 124-8.
26. Hausler M, Schafer C, Osterwinter C, Jah-nen-Dechent W (2009). The physiologic development of fetuin-a serum concen-trations in children. Pediatr Res, 66(6): 660-4.
27. Stefan N, Hennige AM, Staiger H, et al (2006). Alpha2-Heremans-Schmid glyco-protein/fetuin-A is associated with insu-lin resistance and fat accumulation in the liver in humans. Diabetes Care, 29(4): 853-7.
28. Li W, Zhu S, Li J, et al (2011). A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PloS One, 6: e16945.
29. Altinisik HB, Altinisik U, Uysal S, et al (2018). Are Fetuin-A levels beneficial for estimating timing of sepsis occurrence? Saudi Med J, 39(7): 679-84.
| Files | ||
| Issue | Vol 52 No 1 (2023) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v52i1.11670 | |
| Keywords | ||
| Crimean Congo hemorrhagic fever Emergency department Mortality Fetuin-A Lactate | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
